Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note published on Thursday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Up 938.1 %

Shares of AMPE stock opened at $0.02 on Thursday. The firm has a market cap of $24,743.00, a price-to-earnings ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.45.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.